Skip to main content

Diabetes and Osteoporosis

Diabetes and Osteoporosis

Original Air Date : April 12, 2022

Original Air Date : April 12, 2022

There are several risk factors for osteoporosis and osteoporotic fractures including age, sex, fragility fracture after the age of 40, use of glucocorticoid drugs, medications, medical conditions that inhibit absorption of nutrients, in addition to conditions that contribute to bone loss such as diabetes.

Osteoporosis that results from having another disease or condition or from the treatment of another condition is called secondary osteoporosis.

Download “Checklist for your doctor” here.


PRESENTERS

Claudia Gagnon

Claudia Gagnon

MD
Dr. Claudia Gagnon is an Associate Professor in the Department of Medicine at Université Laval and a clinician-researcher scholar of the Fonds de recherche en santé du Québec. She devotes 50% of her time as a researcher at CHU de Québec Research Centre and at Québec Heart and Lung Institute Research Centre in Québec City. She also practices as an adult endocrinologist at CHU de Québec. After completing residency training in adult endocrinology at Université de Sherbrooke in 2006, she undertook a 3-year fellowship in metabolic bone diseases and phosphocalcic metabolism in Melbourne, Australia, under the supervision of Prof. Peter Ebeling and Prof. Robin Daly. Her research focuses on the impact of obesity, diabetes and their treatments (in particular bariatric surgery) on bone health. She received funding from Diabetes Canada, Diabète Québec and the Canadian Institutes of Health Research and published over 50 articles in peer-reviewed journals. She has been awarded the 2019 Jean-Davignon young investigator award from the Cardiometabolic, diabetes and obesity FRQ-S network, the 2017 research prize of the Fédération des médecins spécialistes du Québec and a New Investigator Award from the American Society for Bone and Mineral Research and at the International Symposium on the Nutritional Aspects of Osteoporosis in 2015.

STAY INFORMED

Get Osteoporosis updates, news and stories. We also inform you of upcoming events and live webinars, don’t miss out, join today!

OC REPLAY WEBINARS – RECENT ITEMS

 Biosimilar for Patients on Denosumab

This webinar will provide you with information about the recently approved biosimilar for denosumab by Health Canada. Join Dr. Teri Charrois who will discuss what a biologic and biosimilar are, how they differ from one another, what you need to know when speaking with your healthcare provider and more.

Information for Healthcare Providers on the Health Canada Recently Approved Biosimilar For Denosumab

This webinar for healthcare providers will provide information specific to the Health Canada recently approved biosimilar for denosumab. Join Dr. Angela Cheung as she speaks to how the denosumab biosimilar compares to the reference drug, what physicians can expect from the clinical results, information on treatment p…

Exercise Recommendations in the New Clinical Practice Guideline

The 2023 Clinical Practice Guideline on the Diagnosis and Management of Osteoporosis in Canada has key recommendations and good practice statements with emphasis on significant areas including exercise. Join Osteoporosis Canada as Dr. Lora Giangregorio shares information on physical activity and exercise for bone hea…
© Osteoporosis Canada, 2024
Charitable Registration No. 89551 0931 RR 0001